These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 36612135)

  • 1. Role of Patient-Derived Models of Cancer in Translational Oncology.
    Idrisova KF; Simon HU; Gomzikova MO
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
    Kumari R; Xu X; Li HQ
    Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts.
    Lee S; Burner DN; Mendoza TR; Muldong MT; Arreola C; Wu CN; Cacalano NA; Kulidjian AA; Kane CJ; Jamieson CAM
    J Vis Exp; 2020 Feb; (156):. PubMed ID: 32065165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models.
    Wang E; Xiang K; Zhang Y; Wang XF
    J Natl Cancer Cent; 2022 Dec; 2(4):263-276. PubMed ID: 39036550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
    Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
    PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
    Thorel L; Morice PM; Paysant H; Florent R; Babin G; Thomine C; Perréard M; Abeilard E; Giffard F; Brotin E; Denoyelle C; Villenet C; Sebda S; Briand M; Joly F; Dolivet E; Goux D; Blanc-Fournier C; Jeanne C; Villedieu M; Meryet-Figuiere M; Figeac M; Poulain L; Weiswald LB
    J Exp Clin Cancer Res; 2023 Oct; 42(1):260. PubMed ID: 37803448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.
    DeBord LC; Pathak RR; Villaneuva M; Liu HC; Harrington DA; Yu W; Lewis MT; Sikora AG
    Am J Cancer Res; 2018; 8(8):1642-1660. PubMed ID: 30210932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research.
    Xu X; Shang L; Wang P; Zhou J; Ouyang X; Zheng M; Mao B; Zhang L; Chen B; Wang J; Chen J; Qian W; Guo S; Huang Y; Li QX
    J Vis Exp; 2021 May; (171):. PubMed ID: 34028430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery.
    Kim YS; Hsieh AC; Lam HM
    Eur Urol Focus; 2022 May; 8(3):657-659. PubMed ID: 35915037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.
    Chew NJ; Lim Kam Sian TCC; Nguyen EV; Shin SY; Yang J; Hui MN; Deng N; McLean CA; Welm AL; Lim E; Gregory P; Nottle T; Lang T; Vereker M; Richardson G; Kerr G; Micati D; Jardé T; Abud HE; Lee RS; Swarbrick A; Daly RJ
    Breast Cancer Res; 2021 Aug; 23(1):82. PubMed ID: 34344433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor spheroids and organoids as preclinical model systems.
    Baniahmad A
    Med Genet; 2021 Sep; 33(3):229-234. PubMed ID: 38835698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Takada K; Aizawa Y; Sano D; Okuda R; Sekine K; Ueno Y; Yamanaka S; Aoyama J; Sato K; Kuwahara T; Hatano T; Takahashi H; Arai Y; Nishimura G; Taniguchi H; Oridate N
    Int J Cancer; 2021 Jan; 148(1):193-202. PubMed ID: 32984947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.
    Xiang K; Wang E; Mantyh J; Rupprecht G; Negrete M; Sanati G; Hsu C; Randon P; Dohlman A; Kretzschmar K; Bose S; Giroux N; Ding S; Wang L; Balcazar JP; Huang Q; Sundaramoorthy P; Xi R; McCall SJ; Wang Z; Jiang C; Kang Y; Kopetz S; Crawford GE; Lipkin SM; Wang XF; Clevers H; Hsu D; Shen X
    Adv Sci (Weinh); 2024 Apr; 11(16):e2303379. PubMed ID: 38380561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Patient-Derived Cancer Organoids to Personalized Medicine.
    Shiihara M; Furukawa T
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine.
    Gilazieva Z; Ponomarev A; Rutland C; Rizvanov A; Solovyeva V
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.